Kodiak Sciences Inc KOD Ratios & Valuation
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Returns | ||||||
| Return on equity | -208.8%-99.9pp | -149.5%-64.8pp | -207.9%-129pp | -140.3%-68.8pp | -108.9%-35.5pp | |
| Return on assets | -76.4%-24.4pp | -66.9%-23.7pp | -73.6%-31.9pp | -60.7%-20.8pp | -52%-8.7pp | |
| Liquidity | ||||||
| Current ratio | 3.5×-1.1× | 4.7×-2.0× | 1.8×-6.6× | 3.5×-7.1× | 4.6×-5.5× | |
| Quick ratio | 3.5×-1.1× | 4.7×-2.0× | 1.8×-6.6× | 3.5×-7.1× | 4.6×-5.5× | |
| Cash ratio | 3.4×-1.1× | 4.6×-2.0× | 1.7×-6.5× | 3.4×-7.0× | 4.5×-5.4× | |
| Leverage | ||||||
| Debt-to-equity | 0.5×-0.1× | 0.4×-0.1× | 2.6×+2.2× | 0.9×+0.6× | 0.6×+0.3× | |
| Debt-to-assets | 0.2×0.0× | 0.2×0.0× | 0.3×+0.1× | 0.3×+0.1× | 0.2×0.0× | |
| Per Share | ||||||
| Book value per share | $1.81-12.2% | $2.96+3.5% | $0.45-87.3% | $1.33-67.4% | $2.06-55.1% | |
| Valuation | ||||||
| Market capitalization | $2.33B+1,477% | $1.71B+226% | $864.69M+530% | $190.48M+54.4% | $147.61M-46.5% | |
| Enterprise value | $2.21B+2,798% | $1.56B+265% | $854.85M+6,611% | $151.52M+855% | $76.4M-29.6% | |
| Price / book | 20.8×+19.4× | 10.8×+7.4× | 36.5×+35.8× | 2.7×+2.1× | 1.4×+0.2× | |
| Free cash flow yield | -6.4%+66.4pp | -8%+14.5pp | -14.7%+92.6pp | -60.7%+68.0pp | -72.8%-9.1pp | |
| Earnings yield | -9.9%+119pp | -13.5%+20.2pp | -25.1%+115pp | -104.9%+55.3pp | -129.1%-44.8pp |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where do Kodiak Sciences Inc's ratios come from?
- Every ratio is computed from Kodiak Sciences Inc's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.